Ajanta Pharma

Ajanta Pharma is a multinational specialty pharmaceutical company founded in 1973 and headquartered in Mumbai, India. The company develops, manufactures, and markets high-quality branded generics and generic pharmaceuticals across more than 30 countries in Asia, Africa, the Middle East, the CIS region, and the United States.

Ajanta Pharma operates across multiple therapeutic categories, including cardiology, dermatology, ophthalmology, pain management, and other key segments. Its product portfolio covers a wide range of dosage forms such as tablets, capsules, injectables, ophthalmic solutions, topical formulations, and other advanced delivery systems. The company is recognized for its strong focus on first-to-market products, offering innovative formulations tailored to evolving patient and market needs.

The company’s manufacturing infrastructure includes several state-of-the-art facilities in India, with select plants approved by leading global regulatory authorities, including the U.S. FDA. In addition, Ajanta Pharma operates a dedicated facility for the production of active pharmaceutical ingredients (APIs). Its robust research and development capabilities—supported by a large team of scientists—enable the development of complex generics and differentiated products.

Ajanta Pharma maintains a diversified business model, combining strong branded generics operations in emerging markets with regulated-market generics in the United States and other developed regions. The company also supplies pharmaceutical products to institutional buyers and public health programs, holding significant presence in therapeutic areas such as antimalarials across select African markets.

From its origins as a small pharmaceutical operation, Ajanta Pharma has grown into a globally recognized company known for its quality manufacturing, patient-centric innovation, and broad international footprint.